HAL vs UTHR · P/E 9.3, $19.05B cap vs P/E 20, rev $2.88B
Halliburton Company (HAL) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the HAL and UTHR stock pages for the full models.
Not investment advice.